The ALPINE trial: Intra-arterial injection of [177Lu]Lu-PSMA-I&T for progressive or recurrent intracranial diffuse glioma; evaluation of safety and appropriate dosage.
Phase 1
- Conditions
- Glioma (diffuse astrocytoma, oligodendroglioma or glioblastoma)Therapeutic area: Diseases [C] - Neoplasms [C04]Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method